Evidence map›Paper›PMID 40055298›Full record

Observational studyArchives of osteoporosis2025

An update in bone mineral density status in Spain: the OsteoSER study.

Carmen Gómez-Vaquero, Marta Domínguez-Álvaro, Daniel Seoane-Mato, Pilar Peris Bernal, Santos Castañeda, Eduardo Kanterewicz Binstock, Ramón Mazzucchelli Esteban, Luis Arboleya Rodríguez, Miguel Bernard, Antonio Álvarez-Cienfuegos and 19 more

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Carmen Gómez-VaqueroRheumatology Department, Hospital Universitari de Bellvitge, Carrer de La Feixa Llarga, S/N, 08907 L'Hospitalet de Llobregat, Barcelona, Spain. carmen.gomez@bellvitgehospital.cat.
Marta Domínguez-ÁlvaroResearch Unit, Sociedad Española de Reumatología, Madrid, Spain.
Daniel Seoane-MatoResearch Unit, Sociedad Española de Reumatología, Madrid, Spain.
Pilar Peris BernalRheumatology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
Santos CastañedaRheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Eduardo Kanterewicz BinstockRheumatology Department, Hospital Universitari de Vic (Consorci Hospitalari de Vic), Barcelona, Spain.
Ramón Mazzucchelli EstebanRheumatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Luis Arboleya RodríguezRheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Miguel BernardRheumatology Department, Hospital Universitario La Paz, Madrid, Spain.
Antonio Álvarez-CienfuegosRheumatology Department, Hospital Vega Baja, Orihuela, Alicante, Spain.
Blanca CorreaClínica Sanz y Correa, A Coruña, Spain.
Luis María Jiménez LiñánRheumatology Department, Hospital Don Benito-Villanueva, Don Benito, Badajoz, Spain.
Carmen Mateo PascualCentro de Salud Fuencarral, Madrid, Spain.
Ma Mercedes Molina Del RioCentro de Atención Primaria Viladecans Montbaig, Sant Climent de Llobregat, Viladecans, Barcelona, Spain.
Mercedes Retamal OrtizCentro de Salud Don Benito Oeste, Don Benito, Badajoz, Spain.
Aida Fátima López LagunaCentro de Salud El Molar, El Molar, Madrid, Spain.
Ruth Molera ValeroCentro de Salud Orihuela, 1-El Rabaloche, Orihuela, Alicante, Spain.
Sara Alvar ParienteCentro de Salud Malpica, Malpica, A Coruña, Spain.
Antonio Pascual-VergaraCentro de Salud Ronda-Norte y Ronda-Sur Santa Bárbara, Ronda, Málaga, Spain.
Adolfo Arias SensoCentro de Salud de Santa Amalia, Santa Amalia, Badajoz, Spain.
Nuria Pérez GutiérrezCentro de Atención Primaria Ramona Via I Pros, El Prat de Llobregat, Barcelona, Spain.
Soledad García FríasCentro de Salud de Cortes de La Frontera, Cortes de La Frontera, Málaga, Spain.
David Bouza AlvárezCentro de Salud Elviña Mesoiro, A Coruña, Spain.
Susana SostrésCentro de Atención Primaria Cap, El Prat de Llobregat, 17 de Setembre, Barcelona, Spain.
Daniel Suárez HernandezCentro de Salud de Benejuzar, Benejuzar, Alicante, Spain.
Ana Zamora CasalCentro de Salud Os Mallos, A Coruña, Spain.
Cristina García RamírezCentro de Salud Ronda-Sur Santa Bárbara, Ronda, Málaga, Spain.
Enrique González-DávilaDepartamento de Matemáticas, Estadística E Investigación Operativa, Universidad La Laguna, San Cristóbal de La Laguna, Tenerife, Spain.
OsteoSER Project Collaborative Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone mineral density (BMD) reference data for the Spanish population come from the Multicenter Research Project on Osteoporosis (MRPO) in 1989. The OsteoSER study updated Spanish BMD reference data, showing similarities with MRPO and NHANES III. Peak bone mass occurred at 20-39 years, positively associated with physical activity and negatively with smoking. Osteopenia affected 54.4%, and osteoporosis 10.7% of adults ≥ 50 years, with higher prevalence in women and increasing with age. PURPOSE: This study aimed to estimate the distribution of BMD in lumbar spine, femoral neck, and total hip in the Spanish population aged ≥ 20 years and compare it with MRPO and NHANES III data.

methodsA multicenter cross-sectional observational study was conducted in a White Spanish population aged 20-80 years across 12 urban and rural municipalities. Participants were selected by primary care physicians based on inclusion criteria (stratified by sex, age, and BMI) and exclusion criteria (artifacts in BMD imaging in participants of all ages and conditions affecting bone density in younger participants). A vehicle with a Hologic® Horizon W densitometer traveled to each municipality.

resultsA total of 1522 participants underwent densitometry (51.8% men). Peak bone mass is reached at ages 20-39 years in both sexes at all sites. BMD was positively associated with height, BMI, and physical activity and negatively with smoking (p < 0.05). The distribution of BMD by age and sex was comparable to MRPO and NHANES III. We found that 54.4% of postmenopausal women and men ≥ 50 years had osteopenia, while osteoporosis was observed in 10.7%, with higher prevalence in women (18.6% vs. 2.6%) and increasing with age. Using MRPO criteria, osteoporosis prevalence rose to 14.8%.

conclusionThe BMD of the OsteoSER study population is similar to that of MRPO and NHANES III. Physical activity positively influences peak bone mass, while smoking has detrimental effects.

Indexed as

Bone DensityOsteoporosisAbsorptiometry, PhotonAdultAgedAged, 80 and overBone Diseases, MetabolicCross-Sectional StudiesFemaleFemur NeckHumansLumbar VertebraeMaleMiddle AgedSpainYoung AdultBone mineral densityDXAOsteopeniaOsteoporosisPeak bone massReference curve

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.